Wilmington, Massachusetts - AdvanSource Biomaterials Corp., a developer of polymer materials for medical devices, has had its patent for antimicrobial polyurethane polymers published, the company said 6 Jan.
AdvanSource is developing a drug-free antimicrobial technology to eradicate clinical infections caused by antibiotic-resistant bacteria associated with medical devices.
The company claim the polyurethane polymers make the surface of components less susceptible to bacterial growth and biofilm formation, reduce the potential for foreign body patient infections and provides longer lasting activity as the antimicrobial agent is "uniformly dispersed throughout the polymer", the company said.
"Our proprietary manufacturing process is differentiated by incorporating the antimicrobial agent during the synthesis process. These antimicrobial formulations are designed to possess a high degree of bacterial 'kill," commented Andrew Reed, vice president of Science and Technology.